RUHS, Jaipur, PB B.Sc Nursing Entrance-2022
Medical Surgical Nursing
Easy

The origin of myeloma is-

Appeared in: RUHS, Jaipur, PB B.Sc Nursing Entrance-2022

Explanation

  • Multiple myeloma is a malignant proliferation of plasma cells, which are a type of white blood cell.
  • These cancerous plasma cells accumulate in the bone marrow, displacing normal blood-forming cells.
  • Plasma cells are terminally differentiated B-lymphocytes, and their primary function is to produce antibodies (immunoglobulins).
  • In myeloma, the neoplastic plasma cells produce a large amount of a single type of immunoglobulin, known as a monoclonal (M) protein.

Why Other Options Were Wrong

  • Option A: Cancers that originate from epithelial cells are known as carcinomas, not myelomas. Epithelial cells line the surfaces of the body and organs.
  • Option B: While plasma cells are a mature form of B-lymphocytes, cancers that arise directly from lymphocytes in lymph nodes or blood are typically classified as lymphomas or lymphocytic leukemias.
  • Option D: Cancers originating from fibrous connective tissues are called sarcomas (e.g., fibrosarcoma). Myeloma arises from hematopoietic cells, not connective tissue.

Related Visual

Visual explanation — Related Visual
Clinical Relevance
  • Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Cellular origin of multiple myeloma as background academic context rather than a clinical decision trigger.
  • Understanding that myeloma originates from plasma cells is crucial for diagnosis. Key diagnostic tests, like serum protein electrophoresis, look for the monoclonal (M) protein produced by these cancerous cells.
  • Treatment strategies for multiple myeloma, such as proteasome inhibitors and immunomodulatory drugs, are designed to specifically target and kill malignant plasma cells.
  • What if? If a bone marrow biopsy showed a massive proliferation of immature granulocytes instead of plasma cells, the diagnosis would be acute myeloid leukemia (AML), not myeloma. This would necessitate a completely different treatment approach, highlighting the importance of identifying the cell of origin.
How to Approach the Question
  • First, identify the core term in the question: 'myeloma'.
  • Recall the definition of myeloma. The prefix 'myel-' refers to bone marrow, and '-oma' means tumor. This points to a cancer within the bone marrow.
  • Consider the cell types that are prominent in the bone marrow. This includes hematopoietic stem cells and their progeny, including plasma cells.
  • Evaluate the options. Associate each cell type with the cancer it causes: Epithelial cells -> Carcinoma; Lymphocytes -> Lymphoma/Leukemia; Fibrous tissue -> Sarcoma.
  • By elimination and direct recall, connect 'myeloma' specifically to 'plasma cells', which are a key component of the bone marrow's immune cell population.
Concept Tested & Keywords
  • Concept Tested: Cellular origin of multiple myeloma
  • Stem keywords: origin, myeloma
  • Lead-in keywords: is

Question ID

QZsBCj0BKUeFR4WUEdEyAk

Reference Book

E6 Pathology- ROBBINS & COTRAN PATHOLOGIC BASIS OF DISEASE 10TH Ed p. 611-613

E6 PATHOLOGY QUICK REVIEWBased on Harsh Mohan Textbook of PATHOLOGY p. 128-130

Practise the full RUHS, Jaipur, PB B.Sc Nursing Entrance-2022

Attempt every question from this paper in a timed mock, then review the full solution for each one.